Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Carl Icahn Wants Changes at Xerox Corp

Carl Icahn is pushing for some big changes at Xerox (XRX) by nominating four candidates to join the company's Board of Directors.

Helios and Matheson Analytics Inc. Stock Soars on Costco MoviePass Deal

Helios and Matheson (HMNY) stock was on the rise today following news of a deal with Costco (COST) concerning MoviePass.

Stitch Fix Inc Starts Getting Analyst Coverage

Stitch Fix (SFIX) stock was on the move today after several analysts starting offering coverage of the stock a few weeks after its IPO.

3 Reasons I Might Be Wrong About Activision Blizzard, Inc. Stock

If these 3 opportunities bear fruit, the current optimism about Activision Blizzard, Inc. may be justified and ATVI stock will rise further.

Edwards Lifesciences (EW) Ranking Raised to Buy on Robust Earnings Growth

Edwards Lifesciences (NYSE:EW) is ranked as a Buy using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. The shares have been upgraded from a Hold to a Buy in the last week.

Netflix, Inc. Has Long Way To Fall From Top of Its Mountain

Netflix is doing great in the near term, building out a global footprint, but growth will top out, and then the stock will fall.

SEC Warning: The Risks of Bitcoin and Other Cryptocurrencies

A new SEC warning for investors is all about the possible dangers and risks of investing with bitcoin and other cryptocurrencies. 

Superb Measures for Quant Score Make Baxter International (BAX) a Strong Buy

As one of the 782 companies in the GICS Health Care sector Baxter International Inc (NYSE:BAX) is a component of the 161 company Health Care Equipment & Supplies GICS industry group within this sector. BAX has a market value of $34.9 billion which is in the top decile in its industry group. The stock's current Portfolio Grader score places it 9 among the 161 companies in this industry group, positioning it among the leaders; in the top decile of the sector with a ranking of 18 among the 782 companies in the sector, and number 119 in the nearly 5,000 company Portfolio Grader universe.

Snap Inc Stock Surged in the Last Month, but Is It Still a Good Buy?

Despite numerous ominous forecasts, Snap Inc. is growing its revenue streams, which could result in even higher prices for SNAP stock.

Earnings Growth Keep Boston Scientific (BSX) a Buy

The current recommendation of Buy for Boston Scientific (NYSE:BSX) has been derived by using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methodology. This represents no change from the previous week and is the same ranking BSX has had from Portfolio Grader for 3 months.

Koninklijke Philips (PHG) a Buy on Superior Quant Score

Koninklijke Philips NV (NYSE:PHG) is one of the 782 companies in the GICS Health Care sector, and a component of the 161 company Health Care Equipment & Supplies GICS industry group within this sector. PHG's market value is $36.0 billion which places it in the top 10% of its industry group. Portfolio Grader's current ranking for PHG puts it 51 among the 161 companies in this industry group, giving it an above-average position; in the top quartile of the sector with a ranking of 190 among the 782 companies in the sector, and number 1,037 in the nearly 5,000 company Portfolio Grader universe.

What an Alibaba Group Holding Ltd and Ford Partnership Could Mean

It's not in and of itself a reason to buy BABA stock, but the partnership between Alibaba and Ford demonstrates a creative, forward-thinking mindset that bodes well.

Why It’s Time for Bears to Back Off From Shopify Inc Stock

The reasoning for betting against Shopify stock is breaking apart. Merchants are embracing the site, and sales volumes are surging.

Superb Metrics for Earnings Momentum Make Intuitive Surgical (ISRG) a Strong Buy

The current recommendation of Strong Buy for Intuitive Surgical Inc (NASDAQ:ISRG) is derived using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 9 months.

Square Inc Still Has Momentum Even After Bitcoin Bites Back

Square rose quickly, then fell, when it started taking Bitcoin in its Cash App.

Stellar Metrics for Earnings Growth Keep Becton Dickinson & Co (BDX) a Strong Buy

Becton Dickinson & Co (NYSE:BDX) is a constituent of the 161 company Health Care Equipment & Supplies GICS industry group, which is part of the 782 company GICS Health Care sector. The market value of BDX is $50.1 billion which falls in the top 10% of its industry group. Portfolio Grader's current ranking for BDX puts it 17 among the 161 companies in this industry group, giving it a well above-average position; in the top decile of the sector with a ranking of 46 among the 782 companies in the sector, and number 268 in the nearly 5,000 company Portfolio Grader universe.

Stryker Corporation’s (SYK) Superior Earnings Growth Keep it a Buy

Stryker Corporation (NYSE:SYK) is one of 161 companies within the Health Care Equipment & Supplies GICS industry group, which is in turn part of the 782 company GICS Health Care sector. SYK has a market value of $56.8 billion which is in the top 10% of its industry group. Portfolio Grader's current ranking for SYK puts it 28 among the 161 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 92 among the 782 companies in the sector, and number 578 in the nearly 5,000 company Portfolio Grader universe.

Danaher Corporation (DHR) a Buy on Robust Earnings Momentum

With a $64.8 billion market value, Danaher Corporation (NYSE:DHR) ranks in the top decile in its industry group, Health Care Equipment & Supplies, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, Portfolio Grader's current ranking for DHR puts it 49 among the 161 companies in this industry group, giving it an above-average position; in the top quartile of the sector with a ranking of 180 among the 782 companies in the sector, and number 998 in the nearly 5,000 company Portfolio Grader universe.

Abbott Laboratories (ABT) a Buy on Strong Earnings Momentum

The current recommendation of Buy for Abbott Laboratories (NYSE:ABT) has been derived by using Louis Navellier's investing methods and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking ABT has had from Portfolio Grader for 3 months.